2014 CME Symposia - Dinner Symposium A

Register for the CMHC today to sign up for these value-added CME/CE activities-at no additional cost!

Pre-registration for symposia will open at the end of August for CMHC registrants to make selections. There are no additional fees to attend. Symposia include meals or refreshments and seating is limited and on a first-come, first-serve basis.

Dinner Symposium A

Thursday · 7:00 - 9:00pm

The Wide Spectrum of Familial Hypercholesterolemia: Discovering Your Highest Risk Patients and Optimizing Treatment

Supported by educational grants from Aegerion Pharmaceuticals, Inc. and Genzyme, A SANOFI COMPANY | Endorsed by The FH Foundation

Symposium Overview

Worldwide, there are at least 20 million people with familial hypercholesterolemia (FH). Despite the availability of effective treatment options and the prevalence of the disease, FH is both underdiagnosed and undertreated. This symposium will address knowledge and practice gaps in the identification and management of patients with severe FH. The faculty will provide expert recommendations for diagnosing FH and cascade family screening, and will present the most current evidence on novel therapeutic options. Patient Advocates from The FH Foundation will share their personal experiences with this life-threatening disease and efforts to improve awareness and encourage proactive treatment.

Learning Objectives

  • Review the prevalence and associated cardiovascular risk of familial hypercholesterolemia (FH) in order to increase awareness and understanding of the disease.
  • Describe the pathophysiology of familial hypercholesterolemia and list genetic variants that cause an increase in LDL-C levels and therefore cardiovascular risk.
  • Explain how to implement screening strategies in pediatric and adult patients for prompt diagnosis of FH and early treatment.
  • Describe current guidelines in clinical practice for screening, diagnosis, and management of individuals with FH.
  • Review novel pharmacologic treatment options as well as LDL apheresis to overcome limitations of current treatment options and to determine management plans to optimize outcomes.
  • Provide strategies for overcoming provider-patient barriers in communication to help individuals with FH recognize and appreciate their level of risk, the importance of family screening and the need to adhere to therapy.

Preliminary Agenda & Faculty

7:00 - 7:15pm Familial Hypercholesterolemia: The Evolution of a Disease over the Last 40 Years Chairperson: Seth J. Baum, MD
7:15 - 7:40pm Strategies for Early Identification, Diagnosis, and Cascade Screening Presenter: Sarah de Ferranti, MD, MPH
7:40 - 8:20pm Advanced Approaches for Optimizing Outcomes in the Severe FH Patient Presenters: Patrick Moriarty, MD and Pamela Morris, MD
8:20 - 8:35pm The Faces of Familial Hypercholesterolemia: A Call to Action from the FH Community Presenters: Catherine Davis Ahmed and Scott Radabaugh
8:35 - 9:00pm Key Take-Home Messages, Panel Discussion and Audience Q&A Moderator: Seth J. Baum, MD
Presenters: Catherine Davis Ahmed; Sarah de Ferranti, MD, MPH; Patrick Moriarty, MD; Pamela Morris, MD; Scott Radabaugh

Seth J. Baum, FASPC, MD**

  • Immediate Past-President, American Society for Preventive Cardiology
  • Excel Medical Clinical Trials, LLC
  • Founder, Chief Medical Officer
  • Clinical Affiliate Professor of Biomedical Science
  • Department of Integrated Medical Sciences
  • Florida Atlantic University
  • Charles E. Schmidt College of Medicine
  • Medical Director, Women’s Preventive Cardiology
  • Christine E. Lynn Women’s Health & Wellness Institute
  • Boca Raton Regional Hospital
  • Boca Raton, FL

Sarah de Ferranti, MD, MPH

  • Director, Preventive Cardiology Program
  • Assistant Professor of Pediatrics
  • Harvard Medical School

Patrick M. Moriarty, MD

  • Professor of Medicine
  • Kansas University Medical Center
  • Director of Clinical Pharmacology
  • The University of Kansas Health System
  • Kansas City, KS

Scott Radabaugh

  • FH Advocate
  • The FH Foundation

Catherine Davis Ahmed, MBA

  • Vice President, Policy and Outreach
  • The FH Foundation
  • Pasadena, CA

Pamela B. Morris, MD

  • Director, Seinsheimer Cardiovascular Health Program
  • Co-Director, Women's Heart Care
  • Medical University of South Carolina
  • Charleston, SC

View Complete Accreditation Details and Program Overview: CMHC Accreditation